Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks.
about
Isoflavones: Anti-Inflammatory Benefit and Possible CaveatsSustained proliferation in cancer: Mechanisms and novel therapeutic targetsHealthy aging diets other than the Mediterranean: a focus on the Okinawan dietThe potential health effects of dietary phytoestrogensPhytoestrogens and prevention of breast cancer: The contentious debateIn vitro effects of polyphenols on colorectal cancer cells.Seasonality modifies methylation profiles in healthy people.Impact of soy isoflavones on the epigenome in cancer prevention.Epigenetic activities of flavonoids in the prevention and treatment of cancerInduction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.Effects of ginseng on two main sex steroid hormone receptors: estrogen and androgen receptors.Ginseng on Nuclear Hormone Receptors.In vitro-in silico-based analysis of the dose-dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans.Urinary enterolactone associated with liver enzyme levels in US adults: National Health and Nutrition Examination Survey (NHANES).Studies on the antioxidant properties of some phytoestrogens.Conversion of major soy isoflavone glucosides and aglycones in in vitro intestinal models.Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavonesEpigenetics, Plant (Poly)phenolics, and Cancer PreventionBeyond the Antioxidant Activity of Dietary Polyphenols in Cancer: the Modulation of Estrogen Receptors (ERs) Signaling
P2860
Q26746254-71024809-28AA-4A3F-976D-8B46C29E37F8Q28396388-1578B458-D285-4FDC-B947-DC092E73BEC4Q33598993-94AF9677-A3EB-4842-9392-CCA16E06267EQ33676455-6FEABAA5-F200-4FB9-8853-2B9E5B333584Q34031258-2155D64A-3DDA-448B-9A1A-1D92BEBBD734Q34049121-9DF2F6F9-DBD3-4E05-8C6D-F789C1E24BF4Q34166126-4C37F108-E69B-46BF-A0B9-343127F13E38Q34411665-08CC10B9-0601-49EA-A9F8-9341C8A9D77FQ35835175-7C96DC61-0437-4895-955B-0C93B099E1AEQ35843046-33E11714-DEA7-4CEB-B543-5BD14973AE96Q37744377-8404B282-C6FF-402C-BE40-3EC24A6BA4A3Q38613885-17BE44F8-0926-4081-A700-C08AE040DCB4Q38741506-32E11A47-B443-4425-8E0B-F2267E64C49DQ40922281-B108B1C1-96C0-4714-B6E3-B701958FB0D7Q46510284-63386570-F56F-491E-838F-0735EEC44BB9Q46914327-1BA191F9-696E-41E9-9D59-A97EEEDFBBF2Q47157326-1C9B7E7B-CC1D-4209-B8D2-C90DF2110382Q57782660-EF5932AB-8F89-4B24-A4D5-F35C44100CEBQ58762425-E7E1A8C0-8ACF-4F21-B2F8-2EE9995BD0AD
P2860
Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mechanisms underlying the dual ...... roliferation and cancer risks.
@en
type
label
Mechanisms underlying the dual ...... roliferation and cancer risks.
@en
prefLabel
Mechanisms underlying the dual ...... roliferation and cancer risks.
@en
P2093
P2860
P356
P1476
Mechanisms underlying the dual ...... proliferation and cancer risks
@en
P2093
Ana M Sotoca
Jacques Vervoort
Jochem Louisse
P2860
P304
P356
10.1002/MNFR.201200439
P577
2012-11-23T00:00:00Z